Annals of the American Thoracic Society
Scope & Guideline
Advancing pulmonary health through innovative research.
Introduction
Aims and Scopes
- Pulmonary Diseases and Disorders:
The journal covers a wide range of topics related to various pulmonary conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and pulmonary hypertension, with an emphasis on both clinical and translational research. - Critical Care Medicine:
Research in this area includes studies on managing critically ill patients, with a focus on respiratory failure, mechanical ventilation, and the impact of critical illness on long-term outcomes. - Sleep Medicine:
The journal publishes work on sleep-disordered breathing, including obstructive sleep apnea, its impact on overall health, and treatment strategies. - Public Health and Environmental Impacts:
Research addressing the intersections of respiratory health with public health issues, such as air pollution, smoking cessation, and health disparities, is a significant focus. - Innovative Therapeutics:
The journal highlights studies on novel therapeutic approaches, including biologics and pharmacological treatments for various pulmonary conditions. - Multidisciplinary Approaches:
Research that involves collaborative efforts across specialties, including insights from epidemiology, genetics, and health services research, is emphasized to address complex pulmonary issues.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant surge in studies related to the long-term effects of COVID-19 on pulmonary health, including post-COVID syndrome and its management, reflects the ongoing repercussions of the pandemic on respiratory care. - Telemedicine and Remote Patient Monitoring:
The rise of telehealth practices, particularly post-COVID-19, is leading to an increase in research on the effectiveness and implementation of telemedicine in managing chronic respiratory conditions. - Health Disparities and Equity:
There is an increasing focus on health equity, particularly regarding race, socioeconomic status, and access to care, as well as the impact of social determinants of health on pulmonary outcomes. - Artificial Intelligence and Machine Learning Applications:
Emerging research is increasingly utilizing AI and machine learning to improve diagnostics, treatment strategies, and predictive modeling in respiratory diseases. - Environmental Health and Respiratory Disease:
A growing body of literature examines the effects of environmental factors, including air pollution and climate change, on respiratory health, emphasizing the need for interdisciplinary approaches. - Personalized Medicine in Pulmonary Care:
There is a notable trend towards personalized approaches in treatment, particularly in asthma and COPD management, involving genetic, phenotypic, and biomarker-driven strategies.
Declining or Waning
- Traditional Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that do not incorporate newer methodologies or technologies, such as big data analytics or machine learning, which are increasingly in demand. - Basic Science Research:
Although foundational research remains important, there appears to be a waning interest in purely laboratory-based studies without direct clinical implications, as the focus shifts towards translational research with immediate applications in patient care. - Single-Disease Focus:
Research that concentrates on single diseases in isolation is becoming less common, with a broader trend towards studies that consider comorbid conditions and the interconnectedness of various pulmonary disorders. - Outdated Treatment Protocols:
As new guidelines and treatment modalities emerge, older treatment protocols and their efficacy are being phased out, leading to fewer studies focused on traditional management strategies. - Non-comprehensive Health Disparities Studies:
Research focusing solely on health disparities without integrating social determinants of health or systemic factors has seen a decline, as the field moves towards more holistic approaches.
Similar Journals
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Fostering Excellence in Respiratory Research and InnovationThe AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.
Egyptian Journal of Bronchology
Advancing respiratory health through open access research.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
Chronic Respiratory Disease
Transforming insights into improved patient care.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
Pulmonology
Unleashing the latest in pulmonary and respiratory medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Exploring innovative solutions for better patient outcomes.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Turkish Thoracic Journal
Advancing pulmonary health through innovative research.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
BMJ Open Respiratory Research
Connecting researchers and practitioners for impactful respiratory solutions.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
THORAX
Advancing pulmonary knowledge, one study at a time.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
CHEST
Connecting researchers and practitioners for impactful healthcare solutions.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
BMC Pulmonary Medicine
Fostering collaboration and knowledge in respiratory care.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.